Avanos Medical, Inc.
Hedge Funds Holdings
Last updated:
Avanos Medical, Inc.‘s stocks are currently a part of 204 hedge funds’ portfolios, which represents 59.13% of the total amount of its stocks outstanding. This makes up a total of 27.97M shares of Avanos Medical, Inc.. Compared to the previous quarter, the number fell by -35.43% or -15.34M shares fewer. As for the holding position changes, 25.98% (53) of current hedge fund investors increased the number of shares held, 27.94% (57) of current holders sold a part of the shares held, and 7.35% (15) closed the holdings completely. 24 hedge funds are new holders of Avanos Medical, Inc. stock in Q1 2023, it is 11.76% of total holders.
Hedge funds holding Avanos Medical (Q2 2018 – Q1 2023)
Q2 2018 | 34 |
---|---|
Q3 2018 | 366 |
Q4 2018 | 324 |
Q1 2019 | 313 |
Q2 2019 | 296 |
Q3 2019 | 260 |
Q4 2019 | 257 |
Q1 2020 | 237 |
Q2 2020 | 245 |
Q3 2020 | 236 |
Q4 2020 | 253 |
Q1 2021 | 265 |
Q2 2021 | 241 |
Q3 2021 | 238 |
Q4 2021 | 258 |
Q1 2022 | 257 |
Q2 2022 | 239 |
Q3 2022 | 223 |
Q4 2022 | 269 |
Q1 2023 | 204 |
Hedge funds changes in Avanos Medical positions (Q2 2018 – Q1 2023)
Q2 2018 | 34 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q3 2018 | 335 | 6 | 12 | 1 | 12 |
Q4 2018 | 48 | 86 | 99 | 88 | 3 |
Q1 2019 | 33 | 86 | 90 | 41 | 63 |
Q2 2019 | 41 | 76 | 94 | 51 | 34 |
Q3 2019 | 22 | 69 | 74 | 59 | 36 |
Q4 2019 | 43 | 56 | 81 | 38 | 39 |
Q1 2020 | 28 | 70 | 63 | 46 | 30 |
Q2 2020 | 30 | 62 | 76 | 19 | 58 |
Q3 2020 | 28 | 43 | 89 | 35 | 41 |
Q4 2020 | 48 | 48 | 94 | 31 | 32 |
Q1 2021 | 46 | 58 | 76 | 31 | 54 |
Q2 2021 | 24 | 78 | 65 | 49 | 25 |
Q3 2021 | 32 | 69 | 66 | 32 | 39 |
Q4 2021 | 51 | 78 | 62 | 30 | 37 |
Q1 2022 | 35 | 92 | 63 | 33 | 34 |
Q2 2022 | 33 | 75 | 77 | 47 | 7 |
Q3 2022 | 21 | 74 | 74 | 37 | 17 |
Q4 2022 | 70 | 67 | 76 | 21 | 35 |
Q1 2023 | 24 | 53 | 57 | 15 | 55 |
Hedge funds changes in Avanos Medical stock options (Q2 2018 – Q1 2023)
Q2 2018 | 0 | 0 |
---|---|---|
Q3 2018 | 10,439,000 | 6,342,000 |
Q4 2018 | 6,642,000 | 693,000 |
Q1 2019 | 8,765,000 | 4,225,000 |
Q2 2019 | 2,250,000 | 56,000 |
Q3 2019 | 2,019,000 | 1,022,000 |
Q4 2019 | 1,591,000 | 694,000 |
Q1 2020 | 1,210,000 | 2,429,000 |
Q2 2020 | 434,000 | 1,701,000 |
Q3 2020 | 1,687,000 | 1,418,000 |
Q4 2020 | 1,106,000 | 0 |
Q1 2021 | 1,299,000 | 0 |
Q2 2021 | 2,804,000 | 7,000 |
Q3 2021 | 663,000 | 939,000 |
Q4 2021 | 2,074,000 | 6,000 |
Q1 2022 | 679,000 | 6,000 |
Q2 2022 | 279,000 | 2,000 |
Q3 2022 | 0 | 0 |
Q4 2022 | 67,650 | 35,178 |
Q1 2023 | 0 | 0 |